Frequency doubled Nd: YAG (532 nm) laser photocoagulation in corneal vascularisation: Efficacy and time sequenced changes

Indian Journal of Ophthalmology

Volumn 49, Issue 4, 2001, Pages 235-240

  Sharma, Ashok ^a   Samal, Arun ^a   Narang, Subina ^a   Gutpa, Amit ^a   Ram, Jagat ^a   Gupta, Amod ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Corneal opacity; Corneal vascularisation; Laser photocoagulation; Nd:YAG (532 nm) laser

Indexed keywords

ADULT; ARTICLE; CATARACT; CORNEA NEOVASCULARIZATION; FEMALE; HUMAN; LASER COAGULATION; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; CATARACT; CORNEAL NEOVASCULARIZATION; FEMALE; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0142025073     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Thylefors B, Negrel AD, Pararajasegaran R, Dadzie KY. Global data on blindness. Bull WHO 1995;73:116-21.
2. Dandona L, Raghu K, Janar Thanan M, Naduvilath TJ, Shenoy R, Rao GN. Indications for penetrating keratoplasty in India. Indian J Ophthalmol 1997;43:163-68.
3. The Collaborative Corneal Transplantation Studies (CCTS) research group. Effectiveness of histocompatiblity matching in high risk corneal transplantation studies. Arch Ophthalmol 1992;110:1391-93.
4. Maguire MG, Stark WJ, Gottsch JD, Stalling RD, Sugar A, Fink NE, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 1994;101:1536-47.
5. Volker-Dieben HJ, D'Amaro J, Kok-Ven Alphen CC. Heirarchy of prognostic factors for corneal allograft survival. Aust NZJ Ophthalmol 1987;15:11-18.
6. Dua HS, Azuara-Blanco A. Corneal allograft rejection : risk factors, diagnosis, prevention and treatment. Indian J Ophthalmol 1999;47:3-9.
7. Khodadoust AA, Silverstein AM. Transplantation and rejection of individual cell layers of cornea. Invest Ophthalmol 1969;8:180-95.
8. William WL, Richard C, Evelyn MG, Tudah F. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularisation. Invest Ophthalmol Vis Sci 1991;32:2898-5.
9. Cooper CA, Bergamini MKW, Leopord IH. Use of flurbiprofen to inhibit corneal vascularisation. Arch Ophthalmol 1980;98:1102-5.
10. Haynes WL, Proia AD, Klintworth GK. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularisation in rat. Invest Ophthalmol Vis Sci 1989;30:1588-93.
11. Olsen TW, Benegas NM, Joplin AL, Evangelista T, Mindrup EA, Holland EJ. Rapamycin inhibits corneal allograft rejection and neovascularisation. Arch Ophthalmol 1994;112:1471-75.
12. Krasnick NM, Speigelman AV. Comparison of yellow dye, continuous wave Nd:YAG and argon laser on experimentally induced corneal neovascularisation. Journal Of Refractive Surgery 1995;11:45-49.
13. Huang AJW, Watson BD, Hernandez E, Tseng SCG. Photo thrombosis of corneal neovascularisation by intravenous rose bengal and argon laser irradiation. Arch Ophthalmol 1988;106:680-85.
14. Baer JC, Foster CS. Corneal laser photocoagulation of treatment of neovascularisation. Ophthalmology 1992;99:173-79.
15. Nirankari VS. Laser photocoagulation for corneal stromal vascularisation. Tr Am Ophthalmol 1992;90:595-69.
16. Nirankari VS, Dandona L, Rodrigires MM. Laser photocoagulation of experimental corneal stromal vascularisation, efficacy and histopathology. Ophthalmology 1994;100:111-18.
17. Mendelsohn AD, Watson AD, Aefonso EC, Lieb M, Mendelsohn GP, Forster RK, et al. Amelioration of experimental lipid keratopathy by photochemically induced thrombosis for feeder vessels. Arch Ophthalmol 1987;105:983-88.
18. Hemady RK, Berer JC, Foster CS. Bio-microscopic and histopathoscopic observation after corneal laser photocoagulation in a rabbit model of corneal neovascularisation. Cornea 1993;12:185-90.
19. Cherry PMH, Faulkner JD, Shaver RP, Wise JB, Witter SL. Argon laser treatment of corneal neovascularisation. Ann Ophthalmol 1973;5:911-20.
20. Nirnakari VS, Baer JC. Corneal argon laser photocoagulation for neovascularisation in penetrating keratoplasty. Ophthalmology 1986;93:1304-9.
21. Reed JW, Fromer C, Klineworth GK. Induced corneal vascularisation remission with argon laser therapy. Arch Ophthalmol 1975;93:1017-19.
22. Goto S. Q switched Nd: YAG laser treatment for corneal neovascularisation. Jpn Ophthalmol 1992;36:291-300.
23. Corrent G, Roussel TJ, Tseng SCG, Watson BD. Promotion of graft survival by photothrombotic occlusion of corneal neovascularisation. Arch Ophthalmol 1989;107:1501-6.
24. L'Esperance FA. Clinical photocoagulation with organic dye laser - A preliminary communication. Arch Ophthalmol 1985;103:1312-16.
25. L'Esperance FA. Laser sources and ocular effects. In: L'Esperance, editor. Ophthalmic Laser, 3rd edition. St. Louis: The CV Mosby Company; 1989. pp.33-60.
26. Mosier MA, Champion J, Liaw JH, Berns MW. Retinal effects of frequency doubled Nd:YAG (532 nm) laser: Histopathological comparison with argon laser. Laser Surg Med 1895;5:377-404.
27. Marsh RJ. Argon laser treatment of lipid keratopathy. Br J Ophthalmol 1988;72:900-4.
28. Marsh RJ, Marshall J. Treatment of lipid keratopathy with argon laser. Br J Ophthalmol 1982;66:127-35.
29. Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 2000;41:2148-53.